You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / INDOCO REMEDIES

INDOCO REMEDIES
Intrinsic Value | Fundamental Analysis

Returns | 1W : 0.5% , 1M : 20.7%,1Y : 87.9%
BOM : 532612     NSE : INDOCO    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Jun 18,2021
Price(EOD): Rs. 407.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 3,754.38 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
INDOCO REMEDIES 0.5% 20.7% 87.9%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -2.7% 36.8%
DR REDDYS LABORATORIES -3.2% 0.9% 32.7%
DIVIS LABORATORIES -4.4% 3.7% 87%
CIPLA -1.6% 3.9% 48.5%
BIOCON -3.1% 4.1% 0.7%
AUROBINDO PHARMA -4.2% -7.2% 22%
LUPIN -3% -4% 25.2%
TORRENT PHARMACEUTICALS -2.7% 6.3% 16%


FUNDAMENTAL ANALYSIS OF INDOCO REMEDIES

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than INDOCO REMEDIES Premium


VALUATION OF INDOCO REMEDIES

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
154.83
P/E Calculated based on EPS of 2.63
[ Mar2020 - Standalone Results ]

5.52
P/B Calculated based on Book Value of 73.81
[ Mar2020 - Standalone Results ]

3.32
P/S Calculated based on Revenues of 1129.19 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than INDOCO REMEDIES Premium


FAIR VALUE OF INDOCO REMEDIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
333%
137%
96%

SHARE PRICE MOMENTUM OF INDOCO REMEDIES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.38
0.45
0.42
0.42
0.39
0.45
0.42
0.42
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-8.16%
-8.99%
-10.61%
-0.91%
12.07%
63.68%
328.85%
361.3%
QtrlyTrend
0
Latest Qtr: Mar2021

INDOCO REMEDIES related INDICES

BSE Indices1W1M1Y
S&P BSE 250 SMALLCAP -1.2% 6.3% 109.4%
S&P BSE ALLCAP -1.3% 5.3% 67%
S&P BSE 500 -1.3% 5.1% 65.5%
S&P BSE SMALL CAP -1.7% 7.3% 108.4%
S&P BSE MIDSMALLCAP -2% 5.9% 93.9%
S&P BSE 400 MIDSMALLCAP -2% 5.8% 93%
S&P BSE HEALTHCARE -2.9% 1.7% 53.8%
NSE Indices1W1M1Y
NIFTY 500 -1.2% 5.1% 64.9%
NIFTY500 MULTICAP 50:25:25 -1.4% 5.4% NA
NIFTY SMALLCAP250 -1.5% 6% 112.6%
NIFTY MID SMALL400 -2% 5.7% 93.9%

FAQ [Frequently Asked Questions]


Is INDOCO good for long term investment?

As on 18-Jun-2021, the Fundamentals of INDOCO are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of INDOCO REMEDIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INDOCO UnderValued or OverValued?

As on 18-Jun-2021, INDOCO is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of INDOCO ?

As on 18-Jun-2021, the Intrinsic Value of INDOCO is Rs. 171.76 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 94.03
Fair Value [Median EV / Sales Model] : Rs. 171.76
Fair Value [Median Price / Sales Model] : Rs. 208.20
Median Fair Value of INDOCO : Rs. 171.76

Is INDOCO trading at a Premium or Discount?

As on 18-Jun-2021, INDOCO is trading at a Premium of 137% based on the Median Intrinsic Value!

Is it right time to buy INDOCO shares?

As on 18-Jun-2021, INDOCO is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of INDOCO?

Check out Annual Financials of Industry Peers
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with INDOCO?

Compare Analytics
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
INDOCO REMEDIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z